Attached files
| file | filename |
|---|---|
| 8-K/A - FORM 8-K/A - Bausch Health Companies Inc. | a58060e8vkza.htm |
| EX-15.1 - EX-15.1 - Bausch Health Companies Inc. | a58060exv15w1.htm |
| EX-99.3 - EX-99.3 - Bausch Health Companies Inc. | a58060exv99w3.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the inclusion in the Registration Statements of Valeant Pharmaceuticals
International, Inc. (formerly Biovail Corporation) on Form S-3 (No. 333-170478), Form S-4 (No.
333-168254), and Form S-8 (Nos. 333-92229, 333-138697, 333-168629) of our report dated February 23,
2010 relating to the financial statements, financial statement schedule and the effectiveness of
internal control over financial reporting of Valeant Pharmaceuticals International, which appears
in this Current Report on Form 8-K/A of Valeant Pharmaceuticals International, Inc., dated December
8, 2010.
/s/ PricewaterhouseCoopers LLP
Orange County, California
December 8, 2010
Orange County, California
December 8, 2010
1